Moving genetics into clinical cancer care: examples from BRCA gene testing and telemedicine

Breast

Volumn 15, Issue SUPPL. 2, 2006, Pages

  Mackay, James ^a   Taylor, Ailsa ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

BRCA1 2 genetic testing; Informed consent; Patient information; Telemedicine; Translational research

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; CANCER RISK; CANCER THERAPY; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; MEDICAL EXPERT; MEDICAL PRACTICE; NATIONAL HEALTH SERVICE; PATIENT ATTITUDE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RISK BENEFIT ANALYSIS; TELECONFERENCE; TELEMEDICINE; UNITED KINGDOM;

BREAST NEOPLASMS; ENGLAND; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HUMANS; INFORMED CONSENT; PATIENT PARTICIPATION; TELEMEDICINE;

EID: 33947274027     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(07)70021-8     Document Type: Article

References (30)

1. Pober J., and Neuhauser C. Obstacles facing translational research in academic medical centres. FASEB J 15 (2001) 2303-2313
2. Elwyn G., and Charles C. Shared decisions making: the principles and the competences. In: Edwards A., and Elwyn G. (Eds). Evidence Based Patient Choice: Inevitable or Impossible? (2001), Oxford University Press, Oxford 119-143
3. Cancerbackup. "About us". Online at http://www.cancerbackup.org.uk/Aboutus (accessed January 2006).
4. Institute of Human Genetics and Health at University of London (UCL) webpage. www.gene.ucl.ac.uk/IHGH accessed January 2006.
5. Evans D., and Lalloo F. Risk assessment and management of high risk familial breast cancer. J Med Genet 39 (2002) 865-871
6. Hall J., Lee M., Morrow J., et al. Linkage analysis of early onset familial breast cancer to chromosome 17q21. Science 250 (1990) 1684-1689
7. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
8. Wooster R., Bignell G., Swift S., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
9. Irving M., Elmslie F., and Berg J. Genetics of breast cancer 56 9 (2002) 677-682
10. Ford D., Easton D., Stratton M., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62 (1998) 676-689
11. Easton D., Steele L., Fields P., et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61 (1997) 120-128
12. Lynch H., Snyder C., Lynch J., Riley B., and Rubinstein W. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. J Clin Oncol 21 4 (2003) 740-753
13. Second report of the UK National Screening Committee, Department of Health, 2000. Available online at http://www.nsc.nhs.uk/pdfs/secondreport.pdf (accessed January 2006).
14. Hall S. Should public health respect autonomy?. J Med Ethics 18 (1992) 197-201
15. American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21 (2003) 2397-2406
16. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
17. Wooster R., Bignell G., Lancaster J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 6559 (1995) 789-792
18. NICE mission statement. www.nice.org.uk accessed January 2006.
19. Lab21. www.lab-21.com accessed January 2006.
20. National Institute for Clinical Excellence in Health. Clinical guidelines for the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care, May 2004.
21. Department of Health. White Paper Our inheritance, our future: realising the potential of genetics in the NHS, June 2003.
22. Croyle R., and Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 25 (1999) 59-66
23. Cancerbackup. "Breast cancer genetic testing - wide variety in UK services, CancerBACUP survey shows". Online at http://www.cancerbackup.org.uk/News/Mediacentre/Pressreleasesstatements/2005/91989565 (accessed January 2006).
24. Gray J., Brain K., Iredale R., et al. A pilot study of telegenetics. Telemed Telecare 5 (1999) S27-S34
25. Gattas M., MacMillan J., Meinecke I., et al. Telemedicine and clinical genetics: establishing a successful service. J Telemed Telecare 7 (2001) 68-70
26. Coelho J., Arnold A., Nayler J., Tischkowitz M., and MacKay J. An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. Eur J Cancer 41 15 (2005) 2257-2261
27. Mackay J, Nayler J. Turn up, turn on, talk. A videotape of remote cancer genetic clinics, 2005. Available from: Department of Medical Illustration, Great Ormond Street Hospital for Children and the Institute of Child Health, London W1CN 1EH.
28. Cancerbackup and UCL. "BRCA testing: opening the dialogue", 14th December 2005. Report available from Dr James Mackay on request, please e-mail: j.mackay@ucl.ac.uk
29. Department of Health. Best Research for Best Health: A new NHS research strategy, September 2005. available online at: www.dh.gov.uk gateway reference 5923.
30. Department of Health. Summary of responses to the consultation on a new national health strategy, December 05. available online at: www.dh.gov.uk gateway reference 5923.